Get the Weekly Intelligence Brief — top committee picks every Sunday.
RS · NASDAQ · STOCK

Reliance, Inc.

Basic Materials Updated August 09, 2026
$426.21
52W $260.31 – $424.77
67/100
$21.64B
24.5
0.97
AI Committee Verdict
Buy
67/100
Conviction: Unanimous · 100% agreement · 6 analysts
-13.2%
Unanimous

Is RS Bullish or Bearish?

Bullish. Innellis AI committee rates Reliance, Inc. (RS) Buy with a composite score of 67/100 , based on 6 analysts with 100% agreement. Last updated August 09, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +8.20 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -11.80 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The primary driver is low leverage (debt-to-equity 0.20) -- balance sheet can absorb a shock. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull & Bear Case

Bull Case
  • EPS growing 25.5% YoY — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.20) -- balance sheet can absorb a shock — Risk
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • RSI at 72 is in overbought territory — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 09, 2026
Overall Committee Score
67/100
Agreement
100%
Analysts
6
Conviction
Unanimous
Sector Rank
Top 3%
of 54 Basic Materials peers
Value Analyst bullish
62 / 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
Growth Analyst bullish
62 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 25.5% YoY
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− RSI at 72 is in overbought territory
Risk Analyst bullish
80 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.20) -- balance sheet can absorb a shock
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
66 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 15 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 66.8 to 66.8.

Comparing 2026-08-08 to 2026-08-09 (1 day apart).

Technical Analysis

RSI (14)
72.0
Overbought
MACD Histogram
2.303
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.94
Inside Bands
Price vs Moving Averages
EMA 9
$412.91 Above
EMA 21
$403.95 Above
EMA 50
$391.55 Above
EMA 200
$348.24 Above

Fundamental Analysis

Valuation
80
Growth
52
Profitability
42
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio 24.5×
P/B Ratio 2.94×
PEG Ratio 0.96
Dividend Yield 1.16%
52W High $424.77
52W Low $260.31
Quality & Growth
ROE 1031.2%
ROA 712.8%
Gross Margin 2689.3%
Operating Margin 788.0%
Revenue Growth YoY
Debt / Equity 0.27
AI Fundamental Assessment
P/E ratio of 24.5 (inexpensive relative to a 15-40x range); Price-to-book of 2.9x; PEG ratio of 1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 10.3%; Return on assets of 7.1%; Net margin of 5.7%; Gross margin of 26.9%; Current ratio of 4.30 (healthy short-term liquidity); Debt-to-equity of 0.27; Free cash flow per share is positive (10.51); Most recent quarter beat estimates by 12.4%; 2 consecutive earnings beats; EPS growth decelerating (+115.0% -> +21.5% QoQ); Analyst estimates rising over recent quarters
Get the Full RS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore RS Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime